AMP-activated kinase may suppress NADPH oxidase activation in vascular tissues

Med Hypotheses. 2009 Apr;72(4):468-70. doi: 10.1016/j.mehy.2008.12.024. Epub 2009 Jan 31.

Abstract

Activation of AMP-activated kinase (AMPK) suppresses NF-kappaB-mediated transcription in endothelial cells exposed to palmitate or TNF-alpha; it also impedes angiotensin II-driven proliferation in vascular smooth muscle cells. These phenomena become predictable if we postulate that AMPK can inhibit activation of NADPH oxidase. Such an effect would make sense from a homeostatic perspective, and moreover there is direct evidence that AMPK suppresses NADPH oxidase activation in neutrophils. New evidence that sub-pathological levels of peroxynitrite can activate AMPK suggest that this enzyme may act as an "early warning signal" for oxidant stress; inhibiting NADPH oxidase would constitute a rational feedback response to such a signal.

MeSH terms

  • AMP-Activated Protein Kinases / antagonists & inhibitors*
  • AMP-Activated Protein Kinases / metabolism
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / enzymology
  • Enzyme Activation
  • Homeostasis
  • Humans
  • NADPH Oxidases / metabolism*
  • NF-kappa B / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • NADPH Oxidases
  • AMP-Activated Protein Kinases